Mi1250 SYNCHRONY 2 FLEXsoft
Device
MED-EL Corporation
Total Payments
$5.4M
Transactions
2,452
Doctors
397
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.7M | 1,115 | 253 |
| 2023 | $1.5M | 728 | 222 |
| 2022 | $2.2M | 600 | 148 |
| 2021 | $86,285 | 9 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.2M | 131 | 58.7% |
| Long term medical supply or device loan | $1.0M | 78 | 19.1% |
| Travel and Lodging | $449,304 | 665 | 8.3% |
| Consulting Fee | $295,855 | 24 | 5.5% |
| Grant | $192,050 | 36 | 3.6% |
| Food and Beverage | $106,212 | 1,426 | 2.0% |
| Honoraria | $90,319 | 22 | 1.7% |
| Education | $48,882 | 63 | 0.9% |
| Space rental or facility fees (teaching hospital only) | $12,200 | 4 | 0.2% |
| Charitable Contribution | $897.42 | 2 | 0.0% |
| Gift | $155.51 | 1 | 0.0% |
Payments by Type
Research
$3.2M
131 transactions
General
$2.2M
2,321 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Single Sided Deafness and Assymetric Hearing Loss Post Approval Study | MED-EL Corporation | $914,520 | 0 |
| Research Collaboration Agreeement | MED-EL Corporation | $419,771 | 0 |
| Single Sided Deafness and Asymmetric Hearing Loss Post approval study | MED-EL Corporation | $405,437 | 0 |
| Cochlear Implantation in the Single-Sided Deafness in the Medicare Population | MED-EL Corporation | $357,820 | 0 |
| Residual Hearing using MED?EL Cochlear Implants study | MED-EL Corporation | $287,102 | 0 |
| Collaborative Grant - Master CTA | MED-EL Corporation | $272,254 | 0 |
| Expanded Indications in the MED-EL pediatric Cochlear Implant population | MED-EL Corporation | $162,555 | 0 |
| Single Sided Deafness and Asymmetric Hearing LossPost approval study | MED-EL Corporation | $113,775 | 0 |
| Feasibility of Real-Time, Direct Cochlear Nerve Monitoring for Optimization of Concurrent Translabyrinthine Vestibular Schwannoma Resection with Cochlear Implantation | MED-EL Corporation | $75,850 | 0 |
| FPCT-Based Mapping at Initial Act | MED-EL Corporation | $32,275 | 0 |
| Expanded Indications in the Pediatric BONEBRIDGE Population | MED-EL Corporation | $30,173 | 0 |
| MRI Artifact Reduction | MED-EL Corporation | $25,443 | 0 |
| Evaluating and Optimizing Electrically-Evoked Stapedial Reflex Threshold (eSRT) Measurements in Adult Cochlear Implant Recipients | MED-EL Corporation | $19,618 | 0 |
| Optimizing CI for music | MED-EL Corporation | $15,900 | 0 |
| Expanded Indications in the MED-EL Pediatric Cochlear Implant Population | MED-EL Corporation | $10,190 | 0 |
| MED-EL Remote Care Multi-Center Feasibility Study | MED-EL Corporation | $9,695 | 0 |
| Retrospective SSD in Pediatrics | MED-EL Corporation | $4,950 | 0 |
| FPCT-Based Mapping at Activation | MED-EL Corporation | $2,771 | 0 |
| Cochlear Implantation in Pediatric cases of Unilateral Hearing Loss | MED-EL Corporation | $2,250 | 0 |
| Retroactive Fitting of Electric Acoustic Stimulation Processors following Full Length Cochlear Implant Insertion | MED-EL Corporation | $2,209 | 0 |
Top Doctors Receiving Payments for Mi1250 SYNCHRONY 2 FLEXsoft
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Salt Lake City, UT | $4.2M | 235 |
| , MD, PHD | Specialist | Kansas City, KS | $315,521 | 83 |
| Thomas Balkany | — | Miami, FL | $120,500 | 6 |
| , MD | Otolaryngology | Chapel Hill, NC | $105,386 | 211 |
| , MD | Otolaryngology | Iowa City, IA | $55,693 | 73 |
| , M.D | Otology & Neurotology | Raleigh, NC | $29,934 | 18 |
| , MD | Pediatric Otolaryngology | Chicago, IL | $27,260 | 44 |
| , MD | General Practice | Columbus, OH | $23,340 | 37 |
| , M.D | Otology & Neurotology | Pittsburgh, PA | $21,940 | 35 |
| , M.D | Otology & Neurotology | Dallas, TX | $21,305 | 45 |
| , MD | Otolaryngology | Farmington Hills, MI | $20,550 | 40 |
| , M.D | Otology & Neurotology | Stanford, CA | $18,927 | 25 |
| , MD | Otolaryngology | Nashville, TN | $17,845 | 20 |
| , MD | Otolaryngology | Miami, FL | $16,917 | 31 |
| , MD | Otology & Neurotology | Iowa City, IA | $16,516 | 33 |
| , M.D | Otology & Neurotology | Salt Lake City, UT | $14,417 | 32 |
| , M.D | Otology & Neurotology | Chapel Hill, NC | $13,471 | 27 |
| , MD | Student in an Organized Health Care Education/Training Program | Atlanta, GA | $12,821 | 37 |
| , MD | Otology & Neurotology | Little Rock, AR | $11,080 | 30 |
| , MD | Otology & Neurotology | Miami, FL | $9,954 | 10 |
| , MD | Otolaryngology | Chapel Hill, NC | $8,182 | 31 |
| , M.D | Student in an Organized Health Care Education/Training Program | Cincinnati, OH | $7,343 | 5 |
| , M.D | Specialist | Coupeville, WA | $7,000 | 3 |
| , M.D./PH.D | Otolaryngology | Portland, OR | $6,585 | 20 |
| , MD | Otolaryngology | Portland, OR | $6,198 | 19 |
Ad
Manufacturing Companies
- MED-EL Corporation $5.4M
Product Information
- Type Device
- Total Payments $5.4M
- Total Doctors 397
- Transactions 2,452
About Mi1250 SYNCHRONY 2 FLEXsoft
Mi1250 SYNCHRONY 2 FLEXsoft is a device associated with $5.4M in payments to 397 healthcare providers, recorded across 2,452 transactions in the CMS Open Payments database. The primary manufacturer is MED-EL Corporation.
Payment data is available from 2021 to 2024. In 2024, $1.7M was paid across 1,115 transactions to 253 doctors.
The most common payment nature for Mi1250 SYNCHRONY 2 FLEXsoft is "Unspecified" ($3.2M, 58.7% of total).
Mi1250 SYNCHRONY 2 FLEXsoft is associated with 20 research studies, including "Single Sided Deafness and Assymetric Hearing Loss Post Approval Study" ($914,520).